Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 5, 2003, Pages 2348-2351

  Koga, Kaori ^a   Osuga, Yutaka ^a,d   Yoshino, Osamu ^a   Hirota, Yasushi ^a   Ruimeng, Xie ^a   Hirata, Tetsuya ^a   Takeda, Satoru ^b   Yano, Tetsu ^a   Tsutsumi, Osamu ^c   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; FEMALE; GESTATIONAL AGE; HUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOLUBILITY;

ADULT; ENDOTHELIAL GROWTH FACTORS; FEMALE; GESTATIONAL AGE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

FORAMINIFERA;

EID: 0038030642     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021942     Document Type: Article

References (11)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. 1989 Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 161:1200-1204.
2. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. 1991 Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol. 98:648-655.
3. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK. 1996 VEGF mRNA levels in placentae from pregnancies complicated by pre- eclampsia. Br J Obstet Gynaecol. 103:1191-1196.
4. Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ, Gull I, Lessing JB. 1997 Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol. 38:302-306.
5. Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM. 2000 Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol. 183:1554-1557.
6. Ranheim T, Staff AC, Henriksen T. 2001 VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery. Acta Obstet Gynecol Scand. 80:93-98.
7. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ. 1999 Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 106:1019-1022.
8. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. 1998 A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 59:1540-1548.
9. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ. 2002 Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 160:1405-1423.
10. Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, Lip GY. 2001 Plasma levels of vascular endothelial growth factor and its soluble receptor (SFIt-1) in essential hypertension. Am J Cardiol. 87:805-7, A9.
11. He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS. 1999 Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol. 13:537-545.